Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant

Ioannis Sitaras1, Henning Jacobsen2, Melissa M Higdon3

  • 1W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. isitara1@jh.edu.

NPJ Vaccines
|November 15, 2022
PubMed

Related Concept Videos